Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Cancer Causes & Control
Published in: Cancer Causes & Control 1/2016

01-01-2016 | Original paper

Perceived discrimination and cancer screening behaviors in US Hispanics: the Hispanic Community Health Study/Study of Latinos Sociocultural Ancillary Study

Authors: Cristina Valdovinos, Frank J. Penedo, Carmen R. Isasi, Molly Jung, Robert C. Kaplan, Rebeca Espinoza Giacinto, Patricia Gonzalez, Vanessa L. Malcarne, Krista Perreira, Hugo Salgado, Melissa A. Simon, Lisa M. Wruck, Heather A. Greenlee

Published in: Cancer Causes & Control | Issue 1/2016

Login to get access

Abstract

Purpose

Perceived discrimination has been associated with lower adherence to cancer screening guidelines. We examined whether perceived discrimination was associated with adherence to breast, cervical, colorectal, and prostate cancer screening guidelines in US Hispanic/Latino adults.

Methods

Data were obtained from the Hispanic Community Health Study/Study of Latinos Sociocultural Ancillary Study, including 5,313 Hispanic adults aged 18–74 from Bronx, NY, Chicago, IL, Miami, FL, and San Diego, CA, and those who were within appropriate age ranges for specific screening tests were included in the analysis. Cancer screening behaviors were assessed via self-report. Perceived discrimination was measured using the Perceived Ethnic Discrimination Questionnaire. Confounder-adjusted multivariable polytomous logistic regression models assessed the association between perceived discrimination and adherence to cancer screening guidelines.

Results

Among women eligible for screening, 72.1 % were adherent to cervical cancer screening guidelines and 71.3 % were adherent to breast cancer screening guidelines. In participants aged 50–74, 24.6 % of women and 27.0 % of men were adherent to fecal occult blood test guidelines; 43.5 % of women and 34.8 % of men were adherent to colonoscopy/sigmoidoscopy guidelines; 41.0 % of men were adherent to prostate-specific antigen screening guidelines. Health insurance coverage, rather than perceived ethnic discrimination, was the variable most associated with receiving breast, cervical, colorectal, or prostate cancer screening.

Conclusions

The influence of discrimination as a barrier to cancer screening may be modest among Hispanics/Latinos in urban US regions. Having health insurance facilitates cancer screening in this population. Efforts to increase cancer screening in Hispanics/Latinos should focus on increasing access to these services, especially among the uninsured.
Appendix
Available only for authorised users
Literature
1.
Siegel R, Naishadham D, Jemal A (2012) Cancer statistics for Hispanics/Latinos, 2012. CA Cancer J Clin 62:283–298CrossRefPubMed
2.
Klabunde C, Brown M, Ballard-Barbash R et al (2012) Cancer screening—United States, 2010. Centers for Disease Control and Prevention, Atlanta
3.
Wells KJ, Roetzheim RG (2007) Health disparities in receipt of screening mammography in Latinas: a critical review of recent literature. Cancer Control 14(4):369–379PubMed
4.
Byrd T, Chavez R, Wilson K (2007) Barriers and facilitators of cervical cancer screening among Hispanic women. Ethn Dis 17(1):129–134PubMed
5.
Davis JL, Bynum SA, Katz RV, Buchanan K, Green BL (2012) Sociodemographic differences in fears and mistrust contributing to unwillingness to participate in cancer screenings. J Health Care Poor Underserved 23:67–76CrossRefPubMedPubMedCentral
6.
Gonzalez P, Castaneda SF, Mills PJ, Talavera GA, Elder JP, Gallo LC (2012) Determinants of breast, cervical and colorectal cancer screening adherence in Mexican American Women. J Community Health 37(2):421–433CrossRefPubMedPubMedCentral
7.
Jerant AF, Fenton JJ, Franks P (2008) Determinants of racial/ethnic colorectal cancer screening disparities. Arch Intern Med 168(12):1317–1324CrossRefPubMed
8.
Johnson C, Mues K, Mayne S, Kiblawi A (2008) Cervical cancer screening among immigrants and ethnic minorities: a systematic review using the Health Belief Model. J Low Genit Tract Disord 12(3):232–241CrossRef
9.
Soneji S, Armstrong K, Asch DA (2012) Socioeconomic and physician supply determinants of racial disparities in colorectal cancer screening. J Oncol Pract 8(5):125–134CrossRef
10.
Mack KP, Pavao J, Tabnak F, Knutson K, Kimerling R (2009) Adherence to recent screening mammography among Latinas: findings from the California Women’s Health Survey. J Womens Health 18(3):347–354CrossRef
11.
Shariff-Marco S, Klassen A, Bowie J (2010) Racial/ethnic differences in self-reported racism and its association with cancer-related health behaviors. Am J Public Health 100(2):364–374CrossRefPubMedPubMedCentral
12.
Mouton C, Carter-Nolan P, Makambi K, Taylor T (2010) Impact of perceived discrimination on health screening in black women. J Health Care Poor Underserved 21(1):287–300CrossRefPubMedPubMedCentral
13.
Crawley L, Ahn D, Winkleby M (2008) Perceived medical discrimination and cancer screening behaviors of racial and ethnic minority adults. Cancer Epidemiol Biomarkers Prev 17(8):1937–1944CrossRefPubMedPubMedCentral
14.
Facione N, Facione P (2007) Perceived prejudice in healthcare and women’s health protective behavior. Nurs Res 56(3):175–184CrossRefPubMed
15.
Smedley BD, Stith AY, Nelson AR (2003) Institute of Medicine, Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care. Unequal treatment: confronting racial and ethnic disparities in health care. National Academies Press, Washington
16.
17.
LaVange LM, Kalsbeek WD, Sorlie PD et al (2010) Sample design and cohort selection in the Hispanic Community Health Study/Study of Latinos. Ann Epidemiol 20(8):642–649CrossRefPubMedPubMedCentral
18.
Sorlie PD, Avilés-Santa LM, Wassertheil-Smoller S et al (2010) Design and Implementation of the Hispanic Community Health Study/Study of Latinos. Ann Epidemiol 20(8):629–641CrossRefPubMedPubMedCentral
19.
20.
21.
22.
23.
24.
Brondolo E, Kelly K, Coakley V, Gordon T, Thompson S, Levy E (2005) The Perceived Ethnic Discrimination Questionnaire: development and preliminary validation of a community version. J Appl Soc Psychol 35(2):335–365CrossRef
25.
Ahmed NU, Pelletier V, Winter K, Albatineh AN (2013) Factors explaining racial/ethnic disparities in rates of physician recommendation for colorectal cancer screening. Am J Public Health 103(7):e91–e99CrossRefPubMedPubMedCentral
26.
Ye J, Xu Z, Aladesanmi O (2009) Provider recommendation for colorectal cancer screening: examining the role of patients’ socioeconomic status and health insurance. Cancer Epidemiol 33(3):207–211CrossRefPubMed
27.
Benjamins MR (2013) Comparing measures of racial/ethnic discrimination, coping, and associations with health-related outcomes in a diverse sample. J Urban Health 90(5):832–848CrossRefPubMedPubMedCentral
28.
Allgood KL, Rauscher GH, Whitman S, Vasquez-Jones G, Shah AM (2014) Validating self-reported mammography use in vulnerable communities: findings and recommendations. Cancer Epidemiol Biomarkers Prev 23(8):1649–1658CrossRefPubMedPubMedCentral
29.
Howard M, Agarwal G, Lytwyn A (2009) Accuracy of self-reports of Pap and mammography screening compared to medical record: a meta-analysis. Cancer Causes Control 20(1):1–13CrossRefPubMed
30.
Johnson TP, O’Rouke DP, Burris JE, Warneke RB (2005) An investigation of the effects of social desirability bias on the validity of self-reports of cancer screening behaviors. Med Care 43(6):565–573
31.
Klabunde C, Brown M, Ballard-Barbash R, et al (2012) Cancer screening—United States 2010. CDC Morb Mortal Wkly Rep 61(3):41–45
32.
Sabatino SA, White MC, Thompson TD, Klabunde CN (2015) Cancer screening test use—United States, 2013. MMWR Morb Mortal Wkly Rep 64(17):464–468PubMed
33.
American Cancer Society (2013) Cancer prevention and early detection facts and figures. American Cancer Society, Atlanta
34.
Clemans-Cope L, Kenney GM, Buettgens M, Carroll C, Blavin F (2012) The Affordable Care Act’s coverage expansion will reduce differences in uninsurance rates by race and ethnicity. Health Aff 31(5):920–930CrossRef
35.
Metadata
Title
Perceived discrimination and cancer screening behaviors in US Hispanics: the Hispanic Community Health Study/Study of Latinos Sociocultural Ancillary Study
Authors
Cristina Valdovinos
Frank J. Penedo
Carmen R. Isasi
Molly Jung
Robert C. Kaplan
Rebeca Espinoza Giacinto
Patricia Gonzalez
Vanessa L. Malcarne
Krista Perreira
Hugo Salgado
Melissa A. Simon
Lisa M. Wruck
Heather A. Greenlee
Publication date
01-01-2016
Publisher
Springer International Publishing
Published in
Cancer Causes & Control / Issue 1/2016
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-015-0679-0

Other articles of this Issue 1/2016

Cancer Causes & Control 1/2016 Go to the issue

Original paper

Patterns and correlates of accelerometer-assessed physical activity and sedentary time among colon cancer survivors

Original Paper

Family history of hematologic malignancies and risk of multiple myeloma: differences by race and clinical features

Original paper

Obesity, ethnicity, and quality of life among breast cancer survivors and women without breast cancer: the long-term quality of life follow-up study

Original paper

Breast cancer recurrence in relation to antidepressant use

Original paper

Vitamin D, PTH, and calcium and tumor aggressiveness in prostate cancer: a prospective nested case–control study

Original paper

Metformin and prostate cancer mortality: a meta-analysis
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits